Omkar Pharmachem opened higher at ₹6.09, compared with its previous close of ₹5.80. In the last trading session on 12 Nov 2026, the stock traded between ₹6.09 and ₹6.09, with an average traded price of ₹6.09. It showed an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Omkar Pharmachem is now worth
₹ 3,344.00
Resulting in a loss of
₹ 6,656.00 (66.56%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.29 (+5.00%)
Day High
₹6.09
Day Low
₹6.09
Day Open
₹6.09
Prev Close
₹5.80
Volume
11
Value Traded
₹0.00 Cr
1W Return
2.35%
1M Return
-38.22%
3M Return
-61.33%
6M Return
-79.31%
1Y Return
-70.34%
Market Cap (₹ Cr.)
6
PE Ratio
72.50
PB Ratio
0.16
Dividend Yield
-
ROE
0.33%
ROCE
0.45%
Book Value (₹)
36.33
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
2.35%
6 Weeks
-
1 Month
-38.22%
3 Months
-61.33%
9 Months
-74.45%
No data available.
Omkar Pharmachem shareholders approve all AGM resolutions unanimously
All three AGM resolutions passed with 100% votes in favour and zero against. Total valid votes polled stood at 19,39,772, representing 19.23% of outstanding shares. Promoter group cast no votes; public non-institutional holders drove all voting activity. Poll paper votes (19,39,050) significantly outnumbered remote e-votes (722).
1mo agoOmkar Pharmachem profit falls 39% to ₹12.2 lakh in FY26
Net profit fell 39% YoY to ₹12.18 lakh in FY26. Total income declined 13% to ₹47.24 lakh from ₹54.22 lakh. Zero debt position achieved after repaying ₹11.85 lakh loan. Total assets rose to ₹3,669 lakh driven by investment revaluation. 31st AGM scheduled for September 30, 2026.
2mo agoOmkar Pharmachem Q1FY27 net loss widens to ₹1 lakh on rising expenses
Omkar Pharmachem Ltd posted a net loss of ₹1.00 lakh in Q1FY27, reversing a profit of ₹1.50 lakh in Q4FY26. Core operations generated no revenue, with total income limited to ₹9.00 lakh from other sources. Rising other expenses drove the loss despite stable employee benefits.
3mo agoOmkar Pharmachem returns to profitability in FY26
Omkar Pharmachem Limited returned to profitability in FY26 with a net profit of ₹12.18 lakh, compared to a loss in the prior year. Total comprehensive income for the year reached ₹2720.61 lakh, driven by other comprehensive income. The company's balance sheet strengthened significantly, with total assets rising to ₹3669.04 lakh, primarily due to an increase in other investments.
5mo agoOmkar Pharmachem board to meet on May 30 to consider FY26 results
Omkar Pharmachem Limited's board is set to meet on May 30, 2026, to approve audited financial results for the quarter and year ended March 31, 2026. The company also confirmed that the trading window for designated persons and their immediate relatives will remain closed until June 1, 2026.
5mo agoOmkar Pharmachem Limited Announces Special Window for Transfer and Dematerialization of Physical Shares
Omkar Pharmachem Limited has notified BSE Limited of a special window for transfer and dematerialization of physical shares, open from February 05, 2026 to February 04, 2027, in accordance with SEBI Circular No. HO/38/13/11/2026-MIRSD-POD/1/3750/2026 dated January 30, 2026. The facility applies to physical transfer deeds executed prior to April 01, 2019, and requires original share certificates along with relevant supporting documents. Securities transferred under this window will be credited in demat mode and are subject to a one-year lock-in from the date of registration of transfer. Shareholders may contact the company's Registrar, M/s. Alankit Assignments Pvt. Ltd., for further queries.
6mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹19,420.00 | +0.75% | ₹1,75,731.69 | 74.40 | +37.89% | |
| ₹1,550.50 | -1.85% | ₹1,57,822.25 | 59.10 | +4.62% | |
| ₹2,472.50 | -0.18% | ₹73,291.04 | 32.30 | -15.94% | |
| ₹6,823.00 | +0.27% | ₹58,189.43 | 117.40 | +17.62% | |
| ₹4,776.10 | -0.79% | ₹52,465.46 | 79.80 | +29.10% | |
| ₹10,060.50 | +0.92% | ₹51,602.69 | 56.20 | +67.05% | |
| ₹557.30 | -0.93% | ₹28,119.92 | 33.00 | +21.20% | |
| ₹1,671.20 | -1.08% | ₹22,181.48 | 89.90 | +124.73% | |
| ₹1,602.80 | -1.38% | ₹21,861.08 | 20.90 | -7.14% | |
| ₹484.35 | +0.09% | ₹17,562.26 | 29.60 | +21.97% | |
| ₹5,339.00 | +0.12% | ₹16,369.36 | 34.00 | +25.06% | |
| ₹1,246.30 | -0.93% | ₹15,733.02 | 16.10 | -10.54% |
An investment of ₹10,000 made 5 years ago in Omkar Pharmachem is now worth
₹ 3,344.00
Resulting in a loss of
₹ 6,656.00 (66.56%)
Note: Past profits do not guarantee future returns.